Whereas there are a number of cannabis-based companies and corporations that dominate the market, there aren’t any doing what Jay Pharma is doing.
The mission of Jay Pharma is straightforward.
This Canadian-based firm desires to enhance the lives of individuals affected by most cancers by growing state-of-the-art cannabis-based merchandise and mixture therapies that concentrate on unmet wants in most cancers care.
CBD and your complete hashish business are nonetheless so very new and never proof primarily based. The hashish business itself is rather a lot just like the dot com business within the early days.
There are plenty of firms with excessive valuations however solely the businesses with a really good product will survive long run.
Ameri Holdings (Nasdaq: AMRH) to Merge with Jay Pharma
On January 13, Ameri Holdings introduced that that they had entered into an amalgamation settlement with Jay Pharma.
We sat in on a convention name on January 16 to see precisely what this may entail. The replay of the convention name is accessible at +1 412-317-0088 with passcode 10138473.
The aim of the convention name was to debate how Ameri Holdings has entered into the amalgamation settlement whereby the shareholders of Jay Pharma will turn out to be the bulk holders of Ameri Holdings excellent inventory.
The truth that CBD and your complete hashish business are nonetheless very new and never proof primarily based was largely mentioned.
That is the place the chance is.
Proof-based CBD merchandise that may be prescribed by oncologists or that have been obtainable over-the-counter would change the business ceaselessly.
There have already been extraordinarily constructive modifications within the business at massive. The passing of the 2018 Farm Invoice, legalization of leisure hashish in Canada, and the FDA approval of GW Pharma’s Epidiolex are monumental steps within the hashish business.
Hashish and Most cancers Care
Docs are requested on a regular basis by the vast majority of their most cancers sufferers about cannabinoid-based medicines that would assist enhance their most cancers care.
The issue is, docs solely need to use evidence-based merchandise and there’s at the moment a scarcity of those merchandise within the business.
That is one thing Jay Pharma desires to vary.
Dave Johnson, who is ready to step into the position of Jay Pharma Chairman and CEO had the next to say:
“In response to a 2018 survey of 237 medical oncologists, 80% of oncologists focus on medical hashish with sufferers and practically one-half advocate it clinically. Critically, solely 30% of oncologists really feel sufficiently knowledgeable to make suggestions concerning medical hashish, suggesting a big unmet alternative to teach oncologists and supply analysis that helps the protection of medical hashish. In a market that’s extremely underdeveloped with little scientific knowledge, Jay Pharma has the potential to face aside as a developer of cannabinoid-based therapies solely targeted on the wants of most cancers sufferers.”
The Way forward for Jay Pharma
So far, the corporate has filed numerous patents regarding using numerous cannabinoids for particular sorts of most cancers and present most cancers remedies.
Initially, Jay Pharma plans to develop cannabinoid merchandise for these affected by most cancers and the unwanted effects of most cancers remedy. Their long-term imaginative and prescient is the event of a channel of modern mixture therapies that can be utilized along with customary most cancers care remedies, equivalent to chemotherapy and radiation.
To develop these merchandise and mixture therapies, Jay Pharma plans to make use of proprietary affected person knowledge that can assist information product growth and remedy planning.
By means of their method to the event of pharmaceutical and over-the-counter merchandise, they intend to take care of the wants of sufferers, docs and physicians, regulators, and high-value market phase buyers the place an evidence-based method to cannabinoid drugs is remitted.
They plan to do that in partnership with main researchers.
Jay Pharma Companions
Devoted to offering the highest-quality merchandise and mixture therapies, Jay Pharma has partnered with firms and analysis institutes they imagine “have the potential to speed up pharmaceutical efforts, market entry, knowledge assortment, and evaluation.”
Certainly one of these companions is Tikun Olam, Israel’s main medical hashish provider and one of many world’s largest, research-focused medical hashish firms.
Tikun Olam is dedicated to offering evidence-based hashish drugs and their merchandise have been used within the examine of a number of medical trials. Their database consists of over 12,000 folks which were handled for quite a lot of completely different situations, with a central give attention to most cancers.
Jay Pharma will make use of using a proprietary hashish pressure often known as Avidekel, a pressure developed by Tikun Olam with excessive CBD concentrations (18-30%) and low THC (<1%).
Avidekel was licensed to Jay Pharma for the event of OTC and pharmaceutical merchandise that will likely be designed particularly for most cancers sufferers.
St. George’s College of London is one other Jay Pharma companion, which brings analysis expertise and related area data regarding CBD and most cancers.
They’ve additionally partnered with the Soroka College Medical Most cancers Heart, providing scientific analysis capabilities and in depth affected person entry.
Jay Pharma and Cannabinoid-Most cancers Care
Jay Pharma highlights that there’s an rising physique of proof suggesting CBD might have therapeutic, anti-tumor properties in regard to sure sorts of most cancers when used alone or together with current therapies.
Utilizing CBD in Conjunction with Most cancers Therapies
Pointing to preclinical knowledge that means some mixture therapies might enhance sure chemotherapies or most cancers immunotherapies, Jay Pharma is at the moment working to develop modern combos of CBD used along with chemotherapy and immunotherapy most cancers remedies.
Whereas conscious that historically hashish has been used to assist signs of most cancers remedies on account of its appetite-stimulating, analgesic, and anti-emetic properties, Jay Pharma can be considering cannabinoid therapies for his or her potential anti-tumor impact.
Citing analysis suggesting sure pure occurring cannabinoids have a therapeutic, anti-tumor impact, Jay Pharma believes that CBD mixture therapies have the chance to dramatically enhance outcomes in at-risk sufferers.
Additionally they word that there’s proof to counsel that utilizing CBD along with chemotherapy and different particular compounds may very well be more practical than utilizing CBD alone.
Relating to immunotherapy, Jay Pharma notes that preclinical research means that CBD could improve the flexibility of dendritic cells to provide a cytokine would possibly improve the immune system’s response towards sure cancers.
CBD and Most cancers Analysis Research
On their web site, Jay Pharma has included quite a few research concerning CBD/most cancers analysis. They provide a number of research on background analysis that has been executed on cannabinoids and their position in most cancers, together with pre-clinical and scientific assessments of cannabinoids as anti-cancer brokers.
Anybody considering studying extra concerning the numerous research that focus on cannabinoids the position they could play in most cancers is inspired to go to the database of associated research on Jay Pharma’s web site.
Radiodermatitis is among the most typical unwanted effects of radiation, effecting some 95% of people that bear this aggressive most cancers remedy. It will probably differ from a very delicate case of redness on the pores and skin to excessive circumstances the place pores and skin turns into extraordinarily painful and should bleed, crack, and blister.
Jay Pharma is at the moment operating preclinical trials with a cannabinoid-infused topical ointment. They word that apart from the protection profile of CBD, it additionally acts to reasonable signs related to radiodermatitis, together with ache, irritation, wound therapeutic, and oxidative stress.
A number of examples of scientific knowledge that assist CBD’s capability to disrupt the growth and signs of radiodermatitis are included on Jay Pharma’s web site.
Data on the endocannabinoid system and its position in pores and skin homeostasis may also be discovered.
It shouldn’t be lengthy earlier than scientific trials are underway and Jay Pharma can start providing evidence-based CBD merchandise to those that want them most. When this happens, they may focus particularly on pores and skin situations, chemo induced nausea/vomiting, and power ache in sufferers with most cancers.
Featured Picture by Michal Jarmoluk from Pixabay
Final Up to date on